Aprea Therapeutics Q3 EPS $(0.09) Misses $(0.07) Estimate
Benzinga Newsdesk 3 hours ago
NewsEarningsEarnings Misses
Aprea Therapeutics (NASDAQ:APRE) reported quarterly losses of $(0.09) per share which missed the analyst consensus estimate of $(0.07) by 28.57 percent. This is a 80.85 percent increase over losses of $(0.47) per share
Aprea Therapeutics (NASDAQ:APRE) reported quarterly losses of $(0.09) per share which missed the analyst consensus estimate of $(0.07) by 28.57 percent. This is a 80.85 percent increase over losses of $(0.47) per share from the same period last year.